CIK 0001395937 · Large accelerated filer
Syndax Pharmaceuticals Inc
Sign in to watch- Ticker
- SNDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320162505
- Phone
- 781-419-1400
- Business address
- 730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $113,716
- in 1 filing, $114K under 10b5-1 plans
Net −$113,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-09 | Morrison Briggs Director | Sale 10b5-1 | −52,855 | $18.27 | $965K | 17,836 |
| 2023-08-09 | Morrison Briggs Director | Option exercise · Stock Options (Right to buy) 10b5-1 | −52,855 | 0 | ||
| 2023-08-02 | Meury William Director | Option exercise 10b5-1 | +35,000 | $7.11 | $249K | 83,000 |
| 2023-08-02 | Meury William Director | Sale 10b5-1 | −35,000 | $20.46 | $716K | 48,000 |
| 2023-08-02 | Meury William Director | Option exercise 10b5-1 | +24,000 | $7.88 | $189K | 72,000 |
| 2023-08-02 | Meury William Director | Sale 10b5-1 | −24,000 | $20.46 | $491K | 48,000 |
| 2023-08-02 | Meury William Director | Option exercise 10b5-1 | +24,000 | $9.47 | $227K | 72,000 |
| 2023-08-02 | Meury William Director | Sale 10b5-1 | −24,000 | $20.45 | $491K | 48,000 |
| 2023-08-02 | Meury William Director | Option exercise · Stock Options (Right to buy) 10b5-1 | −24,000 | 0 | ||
| 2023-08-02 | Meury William Director | Option exercise · Stock Options (Right to buy) 10b5-1 | −24,000 | 0 | ||
| 2023-08-02 | Meury William Director | Option exercise · Stock Options (Right to buy) 10b5-1 | −35,000 | 0 | ||
| 2023-07-31 | Goldan Keith A. Chief Financial Officer | Other acquisition | +862 | $18.12 | $16K | 3,490 |
| 2023-07-10 | Morrison Briggs Director | Option exercise 10b5-1 | +52,855 | $8.77 | $464K | 70,691 |
| 2023-07-10 | Morrison Briggs Director | Sale 10b5-1 | −52,855 | $20.40 | $1.1M | 17,836 |
| 2023-07-10 | Morrison Briggs Director | Option exercise · Stock Options (Right to buy) 10b5-1 | −52,855 | 0 | ||
| 2023-06-13 | Goldan Keith A. Chief Financial Officer | Sale | −577 | $22.31 | $13K | 2,628 |
| 2023-06-09 | Morrison Briggs Director | Option exercise 10b5-1 | +24,582 | $6.38 | $157K | 42,418 |
| 2023-06-09 | Morrison Briggs Director | Option exercise 10b5-1 | +28,273 | $8.77 | $248K | 70,691 |
| 2023-06-09 | Morrison Briggs Director | Sale 10b5-1 | −24,582 | $21.18 | $521K | 46,109 |
| 2023-06-09 | Morrison Briggs Director | Sale 10b5-1 | −28,273 | $21.18 | $599K | 17,836 |
Page 6 of 15 · 290 trades